Skip to main content
FinSpry Logo
FinSpry
RPRX logo
RPRX
(NASDAQ)
Royalty Pharma plc
$58.60-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Royalty Pharma (RPRX) Stock Price & Financial Analysis

Royalty Pharma Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$57.72 - $58.78
52-Week High$60.44
52-Week Low$34.08
Open$57.89
Volume1.60M
Average Volume (3M)2.91M
Market Cap33.14B
Shares Outstanding559.61M
P/E Ratio (TTM)38.39
Forward P/E50.70
Price to Sales (P/S)13.02
Price to Book (P/B)4.61
EV/EBITDA24.31
Revenue (TTM)2.44B
Net Income (TTM)827.60M
Free Cash Flow (TTM)2.20B
EPS (TTM)$1.48
Profit Margin33.91%
Operating Margin67.93%
Return on Equity (ROE)12.01%
Debt to Equity1.30
50-Day MA$56.53
200-Day MA$47.07
52-Week Change51.06%
Annual Dividend$0.91
Dividend Yield1.60%
Payout Ratio61.51%
Last Dividend Ex-DateAug 14, 2026

Frequently Asked Questions About Royalty Pharma

What is the current stock price for RPRX?

As of the latest trading session, RPRX stock trades at $58.60. The 52-week range is $34.08–$60.44, with a day range of $57.72–$58.78.

What is the P/E ratio for RPRX?

Royalty Pharma's trailing P/E ratio is 38.4, meaning investors pay $38.4 for every $1 of annual earnings. The forward P/E is 50.7, reflecting analyst expectations for future earnings. Royalty Pharma operates in the Healthcare sector.

Does RPRX pay dividends?

Yes, Royalty Pharma pays a 1.60% annual dividend yield ($0.91 per share). The payout ratio is 61.5%. The last ex-dividend date was 2026-08-14.

What do analysts recommend for RPRX?

Based on 3 analysts, the consensus for RPRX is Buy.

What is the market cap of RPRX?

Royalty Pharma's market capitalization is $32.79B, classifying it as a large-cap company. Royalty Pharma operates in the Healthcare sector within the Biotechnology industry.